Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

CANCvsWDNAETF Comparison

ETF 1
CANC

Tema Oncology ETF

This fund is part of
Tomorrow's Treatments
-0.65%
VS
ETF 2
WDNA

WisdomTree BioRevolution Fund

This fund is part of
BioTech & Genomics
-2.11%

Tema Oncology ETF (CANC) belongs to the Tomorrow's Treatments segment. WisdomTree BioRevolution Fund (WDNA) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Healthcare. CANC is more expensive with a Total Expense Ratio (TER) of 0.99%, versus 0.45% for WDNA. CANC is up 18.39% year-to-date (YTD) with +$52M in YTD flows. WDNA performs worse with 16.03% YTD performance, and -$357K in YTD flows. Run a side-by-side ETF comparison of CANC and WDNA below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

CANC vs WDNA performance and flow charts

Performance

0246810%Jun 24Jul 1Jul 9Jul 16Jul 23

Cumulative Flows

-8,000,000-6,000,000-4,000,000-2,000,0000Jun 24Jul 1Jul 9Jul 16Jul 23

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/24/2026
1M3MYTD1Y3Y5Y
Perf.
CANC
WDNA
+4.80%+0.63%
+7.02%+10.94%
+18.39%+16.03%
+52.92%+37.68%
n/a+14.16%
n/a-18.31%
Flows
CANC
WDNA
-$2M-
+$3M-
+$52M-$357K
+$76M-$357K
--$524K
-+$1M
Volatility and drawdown
3M1Y3Y5Y
Volatility
CANC
WDNA
+23.23%+23.94%
+22.67%+25.34%
n/a+25.05%
n/a+24.98%
Max drawdown
CANC
WDNA
-5.93%-8.58%
-9.20%-11.90%
n/a-37.36%
n/a-58.58%
Max drawdown duration
CANC
WDNA
47d17d
67d147d
n/a876d
n/a1786d
Trading data

Create an account to view trading data

Join for free
CANC
WDNA
Last sale
7/27/2026 at 1:30 PM
$41.10
$19.69
Previous close
07/24/2026
$41.07
$19.66
Consolidated volume
07/24/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of July 28, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

CANC
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
CANC
WDNA
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/27/2026 at 1:30 PM
Live
Closed
CANC
WDNA
Last price
$41.10
$19.69
1D performance
+0.09%
+0.14%
AuM$195.60 M$2.55 M
E/R0.99%0.45%
Characteristics
CANC
WDNA
Management strategyActivePassive
ProviderTemaWisdomTree
Benchmark-WisdomTree BioRevolution Index
N° of holdings5680
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateAugust 15, 2023June 3, 2021
ESGNoNo
Advertisement
Exposure

Countries

CANC
USA
80.59%
Switzerland
9.85%
Other
9.56%
WDNA
USA
83.72%
Other
16.28%

Sectors

CANC
Healthcare
99.28%
Other
0.72%
WDNA
Healthcare
89.22%
Other
10.78%
Advertisement

Diversification

CANC

Total weight of top 15 holdings out of 15

55.76%
WDNA

Total weight of top 15 holdings out of 15

39.68%

Top 15 holdings

Data as of June 30, 2026
CANC
Revolution Medicines, Inc.
6.32%
Eli Lilly & Co.
5.24%
Cogent Biosciences, Inc.
4.94%
Novartis AG
4.19%
Roche Holding AG
3.93%
Legend Biotech Corp.
3.70%
Merck & Co., Inc.
3.66%
Bristol Myers Squibb Co.
3.33%
AstraZeneca PLC
3.15%
Johnson & Johnson
3.09%
AbbVie, Inc.
3.08%
Immunome, Inc.
2.87%
Exelixis, Inc.
2.85%
Nuvalent, Inc.
2.73%
IDEAYA Biosciences, Inc.
2.68%
WDNA
Twist Bioscience Corp.
5.81%
Eli Lilly & Co.
3.98%
Moderna, Inc.
3.67%
Johnson & Johnson
2.98%
United Therapeutics Corp.
2.55%
Natera, Inc.
2.32%
Tempus AI, Inc.
2.25%
Immunome, Inc.
2.15%
Beam Therapeutics, Inc.
2.14%
Stoke Therapeutics, Inc.
2.02%
Corteva, Inc.
1.99%
Structure Therapeutics, Inc.
1.98%
Krystal Biotech, Inc.
1.97%
Darling Ingredients, Inc.
1.96%
Ionis Pharmaceuticals, Inc.
1.91%
Frequently asked questions about CANC and WDNA

How have the CANC and WDNA ETFs performed in 2026?

As of July 24, 2026, CANC is up 18.39% year-to-date (YTD), while WDNA has returned 16.03%. That puts CANC better performer ahead so far this year.

Which ETF is attracting more investor money: CANC or WDNA?

Year-to-date, the CANC ETF saw +$52M in flows, compared to -$357K for WDNA.

Which ETF is more volatile: CANC or WDNA?

Over the past year, CANC had a volatility of 22.67%, while WDNA experienced 25.34%.

Which ETF is bigger: CANC or WDNA?

As of July 24, 2026, CANC holds $195.60 M in assets under management (AUM), while WDNA manages $2.55 M.

What sectors do the CANC and WDNA ETFs invest in?

CANC leans toward sectors like Healthcare. Meanwhile, WDNA focuses on Healthcare.

What are the top holdings of the CANC ETF and WDNA ETF?

CANC top holdings include Revolution Medicines, Inc., Eli Lilly & Co. and Cogent Biosciences, Inc.. WDNA holds in its top three: Twist Bioscience Corp., Eli Lilly & Co. and Moderna, Inc..

Which ETF is more diversified: CANC or WDNA?

CANC holds 56 securities with 55.76% of its assets in the top 15. WDNA has 80 securities and a top 15 weight of 39.68%.

Advertisement
Advertisement
Advertisement
Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.

Global ETF Survey 2026